How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

47,808 results for

Hypertension General Measures

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Diagnosis & Assessment of Hypertension - Home Measurement

Diagnosis & Assessment of Hypertension - Home Measurement III. Home BP Measurement | Hypertension Canada Guidelines Subgroup Members: Mark Gelfer, MD; Lyne Cloutier, RN, PhD; Maxime Lamarre-Cliche, MD; Peter Bolli, MD; Guy Tremblay, MD; Donna McLean, RN, NP, PhD; Alain Milot, MD, MSc; Raj Padwal, MD, MSc; Karen Tran, MD; Raymond R. Townsend, MD Central Review Committee: Stella S. Daskalopoulou, MD MSc DIC PhD (Chair); Kaberi Dasgupta, MD MSc; Kelly B. Zarnke, MD MSc; Kara Nerenberg, MD, MSc (...) in this section) or ambulatory BP monitoring before treatment decisions are made (Grade D). Patients should be advised to purchase and use only home BP monitoring devices that are appropriate for the individual and have met standards of the Association for the Advancement of Medical Instrumentation, the most recent requirements of the British Hypertension Society protocol, or the International Protocol for validation of automated BP-measuring devices. Patients should be encouraged to use devices with data

2018 Hypertension Canada

2. Diagnosis & Assessment of Hypertension - Measuring Blood Pressure

Diagnosis & Assessment of Hypertension - Measuring Blood Pressure I. Accurate Measurement of Blood Pressure | Hypertension Canada Guidelines Subgroup Members: Mark Gelfer, MD; Lyne Cloutier, RN, PhD; Maxime Lamarre-Cliche, MD; Peter Bolli, MD; Guy Tremblay, MD; Donna McLean, RN, NP, PhD; Alain Milot, MD, MSc; Raj Padwal, MD, MSc; Karen Tran, MD; Raymond R. Townsend, MD Central Review Committee: Stella S. Daskalopoulou, MD MSc DIC PhD (Chair); Kaberi Dasgupta, MD MSc; Kelly B. Zarnke, MD MSc (...) or if the mean 24-hour SBP is ≥130 mmHg or the DBP is ≥80 mmHg (Grade C). iv. Using home BP monitoring (see Guidelines in , Home BP Monitoring), patients can be diagnosed as hypertensive if the mean SBP is ≥135 mmHg or the DBP is ≥85 mmHg (Grade C). If the office BP measurement is high and the mean home BP is <135/85 mmHg, it is advisable to either repeat home monitoring to confirm the home BP is <135/85 mmHg or perform 24-hour ABPM to confirm that the mean 24-hour ABPM is <130/80 mmHg and the mean awake

2018 Hypertension Canada

3. General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018. (PubMed)

General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018. In the summer of 2016, delegates from the German Respiratory Society, the German Society of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to define consensus-based practice recommendations for the management of patients with pulmonary arterial hypertension (PAH). These recommendations were built on the 2015 European (...) Pulmonary Hypertension guidelines aiming at their practical implementation, considering country-specific issues, and including new evidence, where available. To this end, a number of working groups was initiated, one of which was specifically dedicated to general measures (i.e. physical activity/supervised rehabilitation, pregnancy/contraception, elective surgery, infection prevention, psychological support, travel) and supportive therapy (i.e. anticoagulants, diuretics, oxygen, cardiovascular

Full Text available with Trip Pro

2018 International journal of cardiology

4. The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy

, Issue 3, Pages 270–287 The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy x Stella S. Daskalopoulou Affiliations Division of General Internal Medicine, McGill University, Montreal, Québec, Canada Correspondence Corresponding author: Dr Stella S. Daskalopoulou, McGill University, McGill University Health Centre, Montreal General Hospital, 1650 Cedar Avenue, B2.101.4, Montreal (...) The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy The 2012 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy - Canadian Journal of Cardiology Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 28

2012 CPG Infobase

5. Guidelines for blood pressure measurement, diagnosis, and assessment of risk of pediatric hypertension

Guidelines for blood pressure measurement, diagnosis, and assessment of risk of pediatric hypertension Guidelines Hypertension Canada’s 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, and Assessment of Risk of Pediatric Hypertension Kevin C. Harris, MD, MHSc, a Geneviève Benoit, MD, b Janis Dionne, MD, c Janusz Feber, MD, d Lyne Cloutier, RN, PhD, e Kelly B. Zarnke, MD, MSc, f Raj S. Padwal, MD, MSc, g Doreen M. Rabi, MD, MSc, h and Anne (...) ebec, Canada ABSTRACT We present the inaugural evidence-based Canadian recommendations for the measurement of blood pressure in children and the diagnosis and evaluation of pediatric hypertension. Rates of pediatric hyperten- sion are increasing concomitant with increased rates of childhood obesity. With this, there is growing awareness of the need to measure blood pressure in children. Consequently, the present recommenda- tions have been developed to address an important gap and improve

2016 CPG Infobase

6. Guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension

Guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension Guidelines Hypertension Canada’s 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension Alexander A. Leung, MD, MPH, a Kara Nerenberg, MD, MSc, b Stella S. Daskalopoulou, MD, PhD, c Kerry McBrien, MD, MPH, d Kelly B. Zarnke, MD, MSc, e Kaberi Dasgupta, MD, MSc, c Lyne Cloutier (...) % task force approval were then accepted as ?nal. Recommendations Diagnosis and assessment Two new recommendations and 1 modi?ed recommen- dation have been introduced this year. First, automated of?ce BP (AOBP), taken without patient-health provider interac- tion using a fully-automated device, is now recommended as the preferred method of measuring in-of?ce BP. Second, a modi?ed recommendation has been made to the routine workup for individuals with hypertension. A serum lipid panel (consisting

2016 CPG Infobase

7. In adults with suspected primary hypertension, what is the best method of measuring blood pressure (home, ambulatory or clinic measurement) to assess the response to treatment and prevent cardiovascular events?

In adults with suspected primary hypertension, what is the best method of measuring blood pressure (home, ambulatory or clinic measurement) to assess the response to treatment and prevent cardiovascular events? Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files (...) or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example: Screening

2018 PROSPERO

8. In adults with suspected primary hypertension, what is the best method of measuring blood pressure (home, ambulatory or clinic measurement) to establish the diagnosis and prevent cardiovascular events?

In adults with suspected primary hypertension, what is the best method of measuring blood pressure (home, ambulatory or clinic measurement) to establish the diagnosis and prevent cardiovascular events? Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files (...) or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example: Screening

2018 PROSPERO

9. Hypertension General Measures

Hypertension General Measures Hypertension General Measures Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Hypertension General (...) Measures Hypertension General Measures Aka: Hypertension General Measures , Lifestyle Modification in Hypertension , Nonpharmacologic Management of Hypertension II. Prevention: Habit Changes BP may normalize with 10 pound weight loss alone Weight loss of 10 kg (22 lb) may reduce SBP up to 5-20 mmHg consumption moderated (limit to <1 ounce/day) Beer (<24 ounces/day) Wine (<8 ounces/day) Whiskey 100-Proof (<2 ounces/day) Dynamic Aerobic at least 150 minutes per week Three times per week Thirty minutes

2018 FP Notebook

10. Hypertension Canada's 2018 guidelines for the management of hypertension in pregnancy

and Gynecology, CHU Sainte Justine, Montr eal, Qu ebec, Canada; l Division of General Internal Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada; m Departments of Medicine, Obstetrics and Gynecology, and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada ABSTRACT We present Hypertension Canada’s inaugural evidence-based Cana- dian recommendations for the management of hypertension in preg- nancy. Hypertension in pregnancy is common, affecting approximately (...) in pregnancy is relatively short (often a few weeks to months) compared with studies of hypertension in nonpregnant pop- ulations. Fourth, the clinical outcomes in studies of hyperten- sion in pregnancy are generally not hard cardiovascular outcomes(ie,cardiovasculareventsorcardiovascularmortality), which are associated with higher grades in the Hypertension Canada grading system (Supplemental Table S1). 8 Studies of hypertension in pregnancy use other clinical outcomes (eg, severe hypertension 160/110 mm

2018 CPG Infobase

11. Blood pressure monitoring in kidney transplantation: a systematic review and meta-analysis comparing 24-hour ambulatory, home and clinic blood pressure measurements on hypertension diagnosis and patient outcomes

Blood pressure monitoring in kidney transplantation: a systematic review and meta-analysis comparing 24-hour ambulatory, home and clinic blood pressure measurements on hypertension diagnosis and patient outcomes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files (...) or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example: Screening

2019 PROSPERO

12. Spleen stiffness measurement for the diagnosis of oesophageal varices and clinically significant portal hypertension in patients with advanced chronic liver disease: a meta-analysis of individual patient data

Spleen stiffness measurement for the diagnosis of oesophageal varices and clinically significant portal hypertension in patients with advanced chronic liver disease: a meta-analysis of individual patient data Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears (...) no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion

2019 PROSPERO

13. Examining the use and reporting of outcome measures in studies of rehabilitation in patients with pulmonary hypertension

Examining the use and reporting of outcome measures in studies of rehabilitation in patients with pulmonary hypertension Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any (...) associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example

2019 PROSPERO

14. Meta-analysis of Traditional Chinese Medicine (TCM) constitution identification and intervention measures for effectiveness of essential hypertension

Meta-analysis of Traditional Chinese Medicine (TCM) constitution identification and intervention measures for effectiveness of essential hypertension Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content (...) of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria

2019 PROSPERO

15. Effect of vitamin D on blood pressure and hypertension in the general population: meta-analyses of cohort studies and randomized controlled trials

Effect of vitamin D on blood pressure and hypertension in the general population: meta-analyses of cohort studies and randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content (...) of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria

2019 PROSPERO

16. Diagnosis & Assessment of Hypertension - Renovascular Hypertension

. Hypertension is the most common manifestation, often requiring multiple drugs . Headache, tinnitus, dizziness, neck pain, and cervical/abdominal bruits may also be present . The diagnosis for FMD is based on diagnostic imaging with catheter-based angiography being the ‘gold standard’. Non-invasive imaging modalities include captopril renal scan, duplex ultrasound, computed tomographic angiography and magnetic resonance angiography. Estimates of sensitivity and specificity vary widely and are generally (...) Diagnosis & Assessment of Hypertension - Renovascular Hypertension VII. Assessment for Renovascular Hypertension | Hypertension Canada Guidelines Subgroup Members: Marcel Ruzicka, MD PhD; Sheldon W. Tobe, MD MScCH; Ramesh Prasad, MBBS MSc MA PhD; Michel Vallée, MD PhD; Cedric Edwards, MD Central Review Committee: Stella S. Daskalopoulou, MD MSc DIC PhD (Chair); Kaberi Dasgupta, MD MSc; Kelly B. Zarnke, MD MSc; Kara Nerenberg, MD, MSc; Alexander A. Leung, MD MPH; Kevin C. Harris, MD MHSc; Kerry

2018 Hypertension Canada

17. Diagnosis & Assessment of Hypertension - Endocrine Hypertension

adverse sequelae (stroke, myocardial infarction, arrhythmias, CHF, cardiomyopathy, and particularly abrupt onset of malignant hypertension), and specialized therapeutic interventions, we recommend referral of individuals suspected of having pheochromocytomas/PPGL to centres with experience in their management. Pheochromocytoma/PPGL may present with a wide spectrum of clinical features, including those that are not generally attributed to excess catecholamines . Paroxysmal or severe sustained (...) Meta b 2000;85:1863-7. Brown MA, Cramp HA, Zammit VC, Whitworth JA. Primary hyperaldosteronism: a missed diagnosis in ‘essential hypertensives’? Aust N Z J Med 1996;26:533-8. Hiramatsu K, Yamada T, Yukimura Y, et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hyperrensive patients. Arch Intern Med 1981; 141:1589-93. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF, Jr. Increased

2018 Hypertension Canada

18. Reproducibility of the European Society of Hypertension - International Protocol for validation of blood pressure measuring devices in obese patients. (PubMed)

Reproducibility of the European Society of Hypertension - International Protocol for validation of blood pressure measuring devices in obese patients. Electronic devices for blood pressure (BP) measurements need to go through independent clinical validation as recommended by different authorities, both in general and special populations. Reproducibility of such validation protocols is unknown.The aim of this study was to assess the inter-centre reproducibility of the European Society (...) of Hypertension-International protocol (ESH-IP) in patients with large arm circumference at least 32 cm or obesity.Two independent validation studies were performed in parallel according to the ESH-IP protocol in two centres (Serbia and Armenia). The two studies were performed blindly and independently. The ESH-IP criteria were applied for the analysis. The OMRON RS7 wrist oscillometric devices were used in both studies.The distribution of the mean differences values of 5 or less, 10 or less and 15 mmHg

2019 Journal of Hypertension

19. Differences in knowledge of hypertension by age, gender, and blood pressure self-measurement among the Israeli adult population<sup>✰</sup>. (PubMed)

Differences in knowledge of hypertension by age, gender, and blood pressure self-measurement among the Israeli adult population. Hypertension (HTN) is the most important risk factor for death and disability worldwide. Hypertensive patients' HTN knowledge was shown to be associated with control of HTN. Understanding factors affecting HTN knowledge might help control HTN.To examine differences in HTN knowledge by age, gender, ethnicity, years of education and whether HTN was diagnosed (...) , and to explore whether HTN knowledge is affected by self-measurement of blood pressure (BP), in Israel's general population.A cross-sectional, descriptive, correlational design was used. A convenience sample of 430 Israeli adults, sampled in community centers across Israel, in four age groups (18-34, 35-49, 50-64, and above 64) were interviewed by 17 registered nurses, using a structured questionnaire with open-ended questions, during March 2017 and March 2018. ANOVA and chi-square tests for assessing

2019 Heart & Lung

20. Nation-wide hypertension screening in Italy: data from May Measurements Month 2017-Europe. (PubMed)

awareness of the consequences of hypertension, a generally increased cardiovascular risk and unsatisfactory BP control in 36% of interviewed individuals. An opportunistic cross-sectional survey of volunteers aged ≥18 was carried out in May 2017, during the joint MMM and World Hypertension Day events. Blood pressure measurement, the definition of hypertension and statistical analysis followed the standard MMM protocol. Screenings were conducted both in cities and villages, indoor and outdoor, by health (...) Nation-wide hypertension screening in Italy: data from May Measurements Month 2017-Europe. Elevated blood pressure (BP) is a growing burden worldwide, leading to over 10 million deaths each year. May Measurement Month (MMM) is a global initiative organized by the International Society of Hypertension aimed at raising awareness of high BP and to act as a temporary solution to the lack of screening programs worldwide. A similar approach has been used in Italy since 2012, showing inadequate

Full Text available with Trip Pro

2019 European Heart Journal Supplements

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>